The Velcade Three

The Velcade Three

Latest news »

One year on since NICE recommended Velcade at 1st relapse on the NHS ... What's happened?

3rd November 2008

In the past year we have been busy advising and supporting Myeloma sufferers and their families with regard to accessing Velcade. Our support is not just confined to the UK. We are in contact with Myeloma sufferers world wide.

10 Months on from NICE guidance on Velcade.

27th August 2008

In May of this year we wrote to Myeloma UK, Cancer Charity Cancerbackup and the drug company, Ortho Biotech which makes Velcade.

About The Velcade Three

Jacky Pickles, Janice Wrigglesworth and Marie Morton are three women from Yorkshire who suffer from multiple myeloma - a type of blood cancer. Our fight for access to the life prolonging drug Velcade has been widely reported in the media and we became known as “The Velcade Three”.

About Myeloma and Velcade

  • Myeloma is a cancer of the plasma cells, which attacks and destroys bone, damages the immune system and causes renal failure.
  • The most common symptoms include bone pain, infections and fatigue.
  • Myeloma is currently incurable, but is treatable.
  • Nearly 4,000 new cases will be diagnosed in the UK this year and there are between 14,000 - 20,000 people living with myeloma at any one time in the UK.
  • Public awareness of the disease is very low, despite Myeloma being more prevalent than all but one form of leukaemia and accounting for 15% of all blood cancers.

VELCADE - the latest treatment for Multiple Myeloma is the most effective drug in the treatment of this disease for decades, giving phenomenal results in those who have already been treated.